Clozapine and risperidone influence on cortisol and estradiol levels in male patients with schizophrenia

• Published in: Journal of medicine and life 2015-10, Vol.8 (4), p.548-551
• Main Authors: Piriu, G, Torac, E, Gaman, L E, Iosif, L, Tivig, I C, Delia, C, Gilca, M, Stoian, I, Atanasiu, V
• Format: Article
• Language: English
• Subjects: Adult; Antipsychotic Agents - therapeutic use; Benzodiazepines; Case Presentations; Case-Control Studies; Clozapine - therapeutic use; Estradiol - blood; Humans; Hydrocortisone - blood; Hyperprolactinemia; Male; Middle Aged; Prolactin; Risperidone - therapeutic use; Schizophrenia - blood; Schizophrenia - drug therapy; Young Adult
• ISSN: 1844-122X; 1844-3117

Estrogens role in schizophrenia patients is a subject, which has gained an increased attention from the medical community. Estrogens have been shown to inhibit dopamine actions, improve neuronal regeneration, and overall, have a protective role in the pathology of schizophrenia. The adjunctive estrogen therapy for men is currently under debate. Antipsychotic medication is known to influence the hypothalamo-hypophyseal - gonadal axis by inducing variable degrees of hyperprolactinemia. Several studies have found that some of the atypical antipsychotics lower cortisol levels in patients and also in healthy controls. We have investigated the effects of clozapine and risperidone on estradiol levels in men with schizophrenia. We have also evaluated the levels of prolactin and cortisol, taking into account the possible influence of antipsychotic drugs on both these hormones. Both prolactin and cortisol also have the potential to regulate sexual hormones biosynthesis. Our study found decreased estradiol levels in men with schizophrenia treated with clozapine and risperidone, while prolactin levels were increased only in the risperidone treated group. Cortisol levels are not statistically significant different between groups.